Table II.

Effect of Age, Obesity, and Type 2 Diabetes Status on Mean SeSBP Following 7 to 8 Weeks' Fixed‐Dose Irbesartan/Hydrochlorothiazide 300/25 mg in Pooled Hypertensive Patients^a

Patient subgroup	Baseline, No.	SeSBP Adjusted Mean Change From Baseline
		Mean (SD)	Difference	P Value	95% CI
Age
65 y or older	121	−24.6 (1.5)	−3.6	.015	−6.4 to –0.7
Younger than 65 y	675	−21.0 (1.8)
Obesity
BMI ≥30 kg/m2	378	−22.9 (1.6)
BMI <30 kg/m2	414	−22.7 (1.5)	−0.2	.826	−2.3 to 1.8
Type 2 diabetes
With type 2 diabetes	99	–21.4 (1.9)
Without type 2 diabetes	697	−24.1 (1.5)	2.7	.082	−0.3 to 5.8
aData were adjusted using an analysis of covariance model, for baseline age, body mass index (BMI), type 2 diabetes, sex, race, cholesterol, target organ damage, and acute coronary syndrome. Abbreviations: CI, confidence interval; SeSBP, seated systolic blood pressure.